Information Provided By: 
Fly News Breaks for May 12, 2015
FMI
May 12, 2015 | 08:20 EDT
After Foundation Medicine reported lower than expected Q1 revenue, JMP Securities cut its price target on the name to $57 from $67. However, the firm expects the company's initiatives and upcoming data to yield results. JMP Securities thinks that the stock's current levels create a buying opportunity for longer term investors, and it reiterates an Outperform rating on the shares.
News For FMI From the Last 2 Days
There are no results for your query FMI
